European drugmakers' shares hold firm, despite Trump tariffs

Breakdown

• European pharmaceutical shares held steady after the US announced new import tariffs.
• The US plans to impose a 100% levy on branded drugs, with details on whether these are in addition to existing tariffs still unclear. 6s
• Recent trade deals cap pharmaceutical tariffs, and a preliminary US-EU deal would limit them to 15%, but this is not yet formalized. 24s
• Major drugmakers, including Roche and Novartis, have announced large US investments in response to the tariffs. 41s
• The 100% tariffs will apply only to producers without US operations, and pharmaceutical stocks recovered after initial losses. 52s